Nemdatine 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
IB/0020/G 
This was an application for a group of variations. 
16/01/2024 
B.II.e.5.a.1 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change within 
the range of the currently approved pack sizes 
amended 
on 
SmPC, Annex 
II, Labelling 
and PL 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
B.II.e.5.a.2 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change outside 
the range of the currently approved pack sizes 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.1.b - Replacement or addition of a 
manufacturing site for the FP - Primary packaging 
site 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
life of the finished product - As packaged for sale 
(supported by real time data) 
B.II.e.5.a.1 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change within 
the range of the currently approved pack sizes 
B.II.e.5.a.1 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change within 
the range of the currently approved pack sizes 
B.II.b.3.z - Change in the manufacturing process of 
the finished or intermediate product - Other variation 
B.II.e.5.a.1 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change within 
the range of the currently approved pack sizes 
B.II.e.1.z - Change in immediate packaging of the 
finished product - Other variation 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
Page 2/7 
 
 
 
 
 
responsible for importation and/or batch release - 
Not including batch control/testing 
B.II.e.5.a.2 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change outside 
the range of the currently approved pack sizes 
IB/0018/G 
This was an application for a group of variations. 
30/10/2023 
n/a 
B.I.c.2.b - Change in the specification parameters 
and/or limits of the immediate packaging of the AS - 
Addition of a new specification parameter to the 
specification with its corresponding test method 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
N/0019 
Minor change in labelling or package leaflet not 
14/08/2023 
PL 
connected with the SPC (Art. 61.3 Notification) 
IAIN/0017/G 
This was an application for a group of variations. 
25/04/2023 
SmPC, Annex 
Page 3/7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.1 - Administrative change - Change in the name 
and/or address of the MAH 
II and PL 
IB/0016/G 
This was an application for a group of variations. 
19/07/2022 
n/a 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
B.II.e.2.z - Change in the specification parameters 
and/or limits of the immediate packaging of the 
finished product - Other variation 
IB/0015 
C.I.2.a - Change in the SPC, Labelling or PL of a 
17/11/2021 
22/03/2022 
SmPC, Annex 
generic/hybrid/biosimilar products following 
assessment of the same change for the reference 
product - Implementation of change(s) for which NO 
new additional data is required to be submitted by 
the MAH 
II, Labelling 
and PL 
IAIN/0014 
A.5.a - Administrative change - Change in the name 
29/03/2021 
22/03/2022 
Annex II and 
and/or address of a manufacturer/importer 
responsible for batch release 
PL 
IA/0013 
A.7 - Administrative change - Deletion of 
16/02/2021 
22/03/2022 
Annex II and 
manufacturing sites 
PL 
IA/0012 
B.II.e.1.a.1 - Change in immediate packaging of the 
09/02/2021 
n/a 
finished product - Qualitative and quantitative 
Page 4/7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
composition - Solid pharmaceutical forms 
IB/0011/G 
This was an application for a group of variations. 
08/04/2020 
n/a 
B.I.a.2.a - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
B.I.a.2.e - Changes in the manufacturing process of 
the AS - Minor change to the restricted part of an 
ASMF 
N/0010 
Minor change in labelling or package leaflet not 
10/10/2018 
22/03/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
R/0008 
Renewal of the marketing authorisation. 
09/11/2017 
08/01/2018 
SmPC, Annex 
II, Labelling 
and PL 
IAIN/0009 
B.II.b.1.a - Replacement or addition of a 
24/10/2017 
n/a 
manufacturing site for the FP - Secondary packaging 
site 
N/0007 
Minor change in labelling or package leaflet not 
14/06/2017 
08/01/2018 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
PL 
N/0006 
Update of the labelling to add calendar days as an 
06/07/2016 
24/03/2017 
Labelling and 
option for the starter pack blisters for all four 
strengths. And update of the package leaflet with 
revised contact details of the local representatives 
for Bulgaria, Belgium and Croatia. In addition, the 
MAH took the opportunity to make linguistic and 
editorial amendments to the Maltese, Hungarian, 
PL 
Page 5/7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Czech, Spanish, French, German, Dutch, Swedish 
and Slovenian labelling and package leaflets. 
Minor change in labelling or package leaflet not 
connected with the SPC (Art. 61.3 Notification) 
IB/0005/G 
This was an application for a group of variations. 
13/06/2016 
n/a 
B.I.a.3.a - Change in batch size (including batch size 
ranges) of AS or intermediate - Up to 10-fold 
increase compared to the originally approved batch 
size 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
B.I.b.1.c - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
Page 6/7 
 
 
 
 
 
 
 
 
 
 
 
IAIN/0004 
B.II.b.2.c.1 - Change to importer, batch release 
13/04/2016 
24/03/2017 
Annex II and 
arrangements and quality control testing of the FP - 
PL 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IB/0003 
C.I.z - Changes (Safety/Efficacy) of Human and 
17/07/2015 
13/04/2016 
SmPC, 
Veterinary Medicinal Products - Other variation 
Labelling and 
PL 
IAIN/0002/G 
This was an application for a group of variations. 
24/04/2015 
13/04/2016 
SmPC, Annex 
II, Labelling 
and PL 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
B.II.e.5.a.1 - Change in pack size of the finished 
product - Change in the number of units (e.g. 
tablets, ampoules, etc.) in a pack - Change within 
the range of the currently approved pack sizes 
IAIN/0001 
B.II.b.2.c.2 - Change to importer, batch release 
08/10/2013 
11/11/2014 
SmPC and PL 
arrangements and quality control testing of the FP - 
Including batch control/testing 
Page 7/7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
